CY1107932T1 - Χρηση αναστολεων ιντερλευκινης-18 για αναστολη μεταστασης ογκων - Google Patents

Χρηση αναστολεων ιντερλευκινης-18 για αναστολη μεταστασης ογκων

Info

Publication number
CY1107932T1
CY1107932T1 CY20071100938T CY071100938T CY1107932T1 CY 1107932 T1 CY1107932 T1 CY 1107932T1 CY 20071100938 T CY20071100938 T CY 20071100938T CY 071100938 T CY071100938 T CY 071100938T CY 1107932 T1 CY1107932 T1 CY 1107932T1
Authority
CY
Cyprus
Prior art keywords
interlevkin
suspensions
transfer suspension
tumor transfer
tumor
Prior art date
Application number
CY20071100938T
Other languages
Greek (el)
English (en)
Inventor
Charles Dinarello
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Publication of CY1107932T1 publication Critical patent/CY1107932T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY20071100938T 1999-07-22 2007-07-13 Χρηση αναστολεων ιντερλευκινης-18 για αναστολη μεταστασης ογκων CY1107932T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors
EP00944201A EP1206274B1 (en) 1999-07-22 2000-07-17 Use of interleukin-18 inhibitors to inhibit tumor metastasis

Publications (1)

Publication Number Publication Date
CY1107932T1 true CY1107932T1 (el) 2013-09-04

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100938T CY1107932T1 (el) 1999-07-22 2007-07-13 Χρηση αναστολεων ιντερλευκινης-18 για αναστολη μεταστασης ογκων

Country Status (31)

Country Link
US (1) US7741276B2 (2)
EP (1) EP1206274B1 (2)
JP (1) JP4827352B2 (2)
KR (1) KR100682219B1 (2)
CN (1) CN1173736C (2)
AR (1) AR024907A1 (2)
AT (1) ATE363288T1 (2)
AU (1) AU782478B2 (2)
BG (1) BG65800B1 (2)
BR (1) BR0012675A (2)
CA (1) CA2380216C (2)
CY (1) CY1107932T1 (2)
CZ (1) CZ302114B6 (2)
DE (2) DE1206274T1 (2)
DK (1) DK1206274T3 (2)
EA (1) EA005419B1 (2)
EE (1) EE04838B1 (2)
ES (1) ES2186596T3 (2)
HK (1) HK1048248B (2)
HU (1) HU228780B1 (2)
IL (2) IL131047A0 (2)
MX (1) MXPA02000838A (2)
NO (1) NO329827B1 (2)
NZ (1) NZ516535A (2)
PL (1) PL202477B1 (2)
PT (1) PT1206274E (2)
SK (1) SK287522B6 (2)
TR (1) TR200200169T2 (2)
UA (1) UA73745C2 (2)
WO (1) WO2001007480A2 (2)
ZA (1) ZA200200390B (2)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI335336B (2) 2000-02-10 2011-01-01 Abbott Gmbh & Co Kg
CA2424983A1 (en) 2000-10-11 2002-04-18 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
ES2334773T3 (es) * 2001-05-16 2010-03-16 Yeda Research And Development Co. Ltd. Uso de inhibidores de il-18 para el tratamiento o prevencion de la sepsis.
RU2225720C1 (ru) * 2002-08-12 2004-03-20 Научно-исследовательский институт онкологии Томского научного центра СО РАМН Средство, повышающее противоопухолевую и антиметастатическую активность циклофосфана
MXPA05003869A (es) * 2002-10-08 2005-06-22 Ares Trading Sa El uso de citocina capaz de enlazarse a la proteina de union a interleucina-18, y de inhibir la actividad de una segunda citocina.
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
EP2267024B1 (en) 2005-06-03 2012-05-09 Ares Trading S.A. Production of recombinant Il-18 binding protein
PT1891088E (pt) 2005-06-10 2011-12-19 Ares Trading Sa Processo para a purificação da proteína de ligação il-18
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
PE20251671A1 (es) 2022-03-15 2025-06-30 Compugen Ltd Anticuerpos antagonistas de il-18bp y su uso en monoterapia y terapia de combinacion en el tratamiento del cancer
IL321948A (en) 2023-01-06 2025-09-01 Lassen Therapeutics Inc Anti-IL-18 BP antibodies
TW202515608A (zh) 2023-06-26 2025-04-16 以色列商坎布根有限公司 Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2143748A1 (en) * 1992-09-02 1994-03-17 C. Frank Bennett Oligonucleotide modulation of cell adhesion
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
SK122199A3 (en) * 1997-03-18 2000-12-11 Basf Ag Methods and compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
MXPA02000838A (es) 2002-07-30
ES2186596T1 (es) 2003-05-16
PT1206274E (pt) 2007-07-06
NO20020153D0 (no) 2002-01-11
NO329827B1 (no) 2011-01-03
DE60035049D1 (de) 2007-07-12
EA005419B1 (ru) 2005-02-24
PL202477B1 (pl) 2009-06-30
CZ302114B6 (cs) 2010-10-20
EP1206274A2 (en) 2002-05-22
WO2001007480A2 (en) 2001-02-01
PL353732A1 (en) 2003-12-01
TR200200169T2 (tr) 2002-06-21
JP4827352B2 (ja) 2011-11-30
HUP0202107A2 (en) 2002-10-28
BRPI0012675B1 (pt) 2001-02-01
AU782478B2 (en) 2005-08-04
ZA200200390B (en) 2003-04-30
IL131047A0 (en) 2001-01-28
IL147675A (en) 2009-05-04
KR100682219B1 (ko) 2007-02-12
DE1206274T1 (de) 2002-11-14
CZ2002195A3 (cs) 2002-06-12
ATE363288T1 (de) 2007-06-15
DK1206274T3 (da) 2007-08-13
EA200200189A1 (ru) 2002-12-26
KR20020027493A (ko) 2002-04-13
SK287522B6 (sk) 2011-01-04
SK882002A3 (en) 2002-07-02
BG65800B1 (bg) 2009-12-31
CA2380216C (en) 2012-01-31
WO2001007480A3 (en) 2001-05-10
US20080003216A1 (en) 2008-01-03
BG106311A (en) 2002-08-30
EE200200032A (et) 2003-02-17
ES2186596T3 (es) 2007-11-16
BRPI0012675B8 (2) 2021-05-25
HK1048248B (zh) 2005-04-22
JP2003505472A (ja) 2003-02-12
AR024907A1 (es) 2002-10-30
AU5843200A (en) 2001-02-13
CN1364086A (zh) 2002-08-14
BR0012675A (pt) 2002-04-09
NZ516535A (en) 2004-04-30
NO20020153L (no) 2002-03-11
EP1206274B1 (en) 2007-05-30
HK1048248A1 (en) 2003-03-28
EE04838B1 (et) 2007-06-15
US7741276B2 (en) 2010-06-22
CA2380216A1 (en) 2001-02-01
CN1173736C (zh) 2004-11-03
HU228780B1 (en) 2013-05-28
DE60035049T2 (de) 2007-09-27
UA73745C2 (en) 2005-09-15
HUP0202107A3 (en) 2005-01-28

Similar Documents

Publication Publication Date Title
CY1107932T1 (el) Χρηση αναστολεων ιντερλευκινης-18 για αναστολη μεταστασης ογκων
YU84303A (sh) Postupak dobijanja cetp inhibitora
HRP20070196T3 (hr) Postupak za pročišćavanje il-18 vezivnog proteina
CY1115124T1 (el) Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης
SV2003001103A (es) Formulaciones autoemulsionantes de inhibidores de la proteina de transferencia de colesteril ester pc10894
SE0000540D0 (sv) New compounds
DE69928697D1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
CY1105915T1 (el) Παραγωγα θειαζολιου για τη θepαπεια των παθησεων που σχετιζονται με τους ppar
DE60143520D1 (de) Inhibitoren der histon-deacetylase
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
ATE390629T1 (de) Mikrophysiomessgerät
IL163777A0 (en) Kinase inhibitors
AU2003211093A8 (en) Inhibitors of rgs proteins
DE60229420D1 (de) Neue metallproteinaseinhibitoren
DE60335497D1 (de) Ergillus-phytasen
DE69739346D1 (de) Gereinigtes sr-p70 protein
HRP20050382A2 (en) Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
ATE513041T1 (de) Ghrelin bindende nukleinsäuren
NO20031745L (no) Inhibisjon av vekstfaktoravhengigheten til tumorceller
YU30003A (sh) Inhibicija zavisnosti faktora rasta na ćelije tumora
CY1111289T1 (el) Συνθεσεις αναστολεων ογκου που περιεχουν νιτροακριδινη
DE50311665D1 (de) Guanidinophenylalanin-verbindungen als urokinase-inhibitoren
EA200500624A1 (ru) Промотор для il-18bp, его получение и применение
ATE433953T1 (de) Peptiddeformylaseinhibitoren